Inventor
FLOHR STEFANIE
CH26 patents
⚠️ This page may combine multiple inventors who share the name “FLOHR STEFANIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS DEUTSCHLAND
15 patentsUS7205290B2Apr 17, 2007
Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
SANOFI AVENTIS DEUTSCHLAND28 citations92
US7390790B2Jun 24, 2008
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND9 citations84
US7407938B2Aug 5, 2008
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND5 citations74
US7388004B2Jun 17, 2008
Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND8 citations74
US7488829B2Feb 10, 2009
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SANOFI AVENTIS DEUTSCHLAND5 citations73
US7674773B2Mar 9, 2010
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SANOFI AVENTIS DEUTSCHLAND2 citations63
US7671047B2Mar 2, 2010
Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND6 citations63
US7579339B2Aug 25, 2009
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND3 citations63
US7176194B2Feb 13, 2007
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND4 citations63
US7176193B2Feb 13, 2007
Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SANOFI AVENTIS DEUTSCHLAND2 citations63
US7576200B2Aug 18, 2009
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SANOFI AVENTIS DEUTSCHLAND1 citations62
US7772429B2Aug 10, 2010
Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
SANOFI AVENTIS DEUTSCHLAND0 citations52
US7750005B2Jul 6, 2010
Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7390814B2Jun 24, 2008
Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7652007B2Jan 26, 2010
Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations39
AVENTIS PHARMA GMBH
5 patentsUS6498156B2Dec 24, 2002
Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
AVENTIS PHARMA GMBH60 citations96
US6992067B2Jan 31, 2006
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
AVENTIS PHARMA GMBH41 citations95
US6703386B2Mar 9, 2004
Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
AVENTIS PHARMA GMBH25 citations92
US6962937B2Nov 8, 2005
Imidazolidine derivatives, their preparation and their use
AVENTIS PHARMA GMBH4 citations61
US6841556B2Jan 11, 2005
Pyrazoloisoquinoline derivatives for inhibiting NFκB-inducing kinase
AVENTIS PHARMA GMBH4 citations58
NOVARTIS AG
4 patentsUS9464081B2Oct 11, 2016
Pyrrolidine derivatives and their use as complement pathway modulators
NOVARTIS AG2 citations61
US9487483B2Nov 8, 2016
Complement pathway modulators and uses thereof
NOVARTIS AG2 citations50
US7612054B2Nov 3, 2009
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
NOVARTIS AG0 citations39
US7700605B2Apr 20, 2010
2-cyano-pyrimidines and-triazines as cysteine protease inhibitors
NOVARTIS AG0 citations35